SaaS Survivors: Which ASX Tech Platforms Earned Their Multiple?
Six ASX tech platforms carry quality scores of 8-9/10 and ROIC from 15% to 250%. Every one trades above fair value. The question is which premiums are earned and which are hope.
Six of the ASX's highest-quality technology businesses reported through the February 2026 season. WiseTech Global (WTC), Xero (XRO), Technology One (TNE), Pro Medicus (PME), HUB24 (HUB), and Megaport (MP1) carry business quality scores between 8.0 and 9.0 out of 10 from our pipeline. Return on invested capital (ROIC, a measure of how much profit a business generates relative to the capital it employs) spans from 15% to an extraordinary 250%. EBITDA margins (earnings before interest, tax, depreciation, and amortisation as a percentage of revenue) run from 24% to 78%. These are genuinely excellent businesses. Every one of them trades above our fair value estimate, by gaps ranging from 19% to 78%.
The distinction that matters is between an "earned premium" and a "hope premium." An earned premium reflects proven economics: high ROIC, expanding margins, visible revenue, and a moat that is widening. A hope premium reflects a narrative the market has priced as certainty before the evidence confirms it. The six companies below illustrate both sides. In every case, the quality of the underlying business is not in question. The question is what fraction of that quality has already been paid for at today's prices, and how much room remains for the investor to capture any of the value creation that lies ahead.
Scorecard
| Company | Rating | Price | Fair Value | Gap | Quality | ROIC | EBITDA Margin | Rev Growth |
|---|---|---|---|---|---|---|---|---|
| WTC | HOLD | A$49.00 | A$39.60 | -19% | 8.5/10 | 22% | 40% (FY26E) | 14% organic |
| XRO | Overvalued | A$154.79 | NZ$132.25 | -17% | 8.1/10 | 19% | 8.5% | 27% |
| TNE | AVOID | A$34.34 | A$7.65 | -78% | 8.1/10 | 35% | 44% | 18% ARR |
| PME | SELL | A$116.97 | A$54.22 | -54% | 8.4/10 | 250% | 76% | 29% |
| HUB | SELL | A$97.50 | A$42.23 | -57% | 9.0/10 | 20% | 43% | 28% |
| MP1 | SELL | A$9.65 | A$7.05 | -27% | 8.0/10 | n/a | 24% | 16% organic |
Prices as at February 2026 reporting season. Fair values are probability-weighted DCF estimates from our analysis pipeline. XRO fair value is in NZD; gap calculated on currency-adjusted basis.
WiseTech Global: The Narrowest Gap for a Reason
WiseTech runs CargoWise, the operating system for global freight forwarding, used by 23 of the world's 25 largest logistics companies. Revenue is 95% recurring with sub-1% customer churn sustained for thirteen consecutive years. The LGFF rollout pipeline (large global freight forwarder deployments, where eleven contracted customers have fewer than 20% of users yet live) provides multi-year revenue visibility without incremental sales effort. The e2open acquisition in August 2025 doubled revenue to US$1.4 billion in FY26, and synergies are running 18 months ahead of schedule. ROIC is tracking toward 24% in FY27, supported by EBITDA margins recovering from a 40% integration-year trough toward 48% by FY29.
The investment tension at A$49.00 versus our fair value of A$39.60 is the most moderate in this group: a 19% gap that reflects genuine quality rather than pure hope. At approximately 24x forward EV/EBITDA, the market is pricing the bull scenario (A$46.85, assigned 20% probability in our model) as the base case. Our base case (50% probability) values WTC at A$36.50, our bear case (22% probability) at A$22.75, and our severe downside (8% probability) at A$11.56. The probability-weighted DCF produces A$33.55, and our dynamic fair value incorporating peer multiples reaches A$39.60 using a 9.5% WACC with 3.0% terminal growth.
The risk is not the business quality but the financing structure supporting its transformation. WTC carries A$2.4 billion of acquisition debt, with a Tranche A refinancing of US$572 million falling due in July 2027. Management targets leverage below 3.0x by June 2026; if that is achieved, refinancing should proceed on reasonable terms. A 15% EBITDA miss, however, pushes leverage uncomfortably close to the June 2027 covenant step-down requirement of 3.5x. Under that scenario, a waiver or forced equity raise could crystallise losses of 40 to 50% from current prices. That cascade scenario carries roughly 20 to 25% combined probability across our bear and severe cases. The moat is wide: every new trade regulation, from carbon border adjustments to forced labour supply chain laws to customs digitalisation, extends CargoWise's competitive advantage. But the moat protects the business, not the shareholder who pays A$49 for it.
FY27 is the year the thesis becomes legible. Phase 2 of the AI restructuring, reducing 2,000 roles from product and development, is expected to drive 500 to 900 basis points of margin expansion. Combined with the LGFF revenue ramp and e2open cross-sell opportunity across 500,000 connected enterprises, the growth story has rare visibility for a software company at this scale.
Xero: The Melio Question Dominates Everything
Xero's core cloud accounting platform produces genuinely strong economics: 94% subscription revenue, 1.09% monthly churn (the rate at which customers cancel each month), 4.6 million subscribers, and 65% market share in Australia and New Zealand versus MYOB's 20%. The Rule of 40 score (revenue growth plus free cash flow margin, a standard SaaS efficiency benchmark) sits at 44.5%, outperforming the sector median of 42%. Revenue grew 27% in H1 FY26 to NZ$1,189 million, with annualised monthly recurring revenue reaching NZ$2,734 million. The ecosystem of 200,000-plus accountant partners, who generate 70% of customer referrals, creates genuine two-sided network effects that competitors have not replicated at scale.
Our fair value is NZ$132.25. At A$154.79 (approximately NZ$142 at current exchange rates), the stock trades at a 17% premium. The 90% confidence interval on our fair value runs from NZ$112 to NZ$152. Our bull case of NZ$180.50, assigned 30% probability, requires successful Melio integration, UK Making Tax Digital (MTD) catalyst realisation, and sustained margin recovery. Our bear case of NZ$92.50, assigned 30% probability, reflects integration failure and accelerating churn. The WACC of 13.5% incorporates a 50 basis point acquisition risk premium specifically for Melio.
The A$3.7 billion Melio acquisition is the binary variable that shapes the entire investment case. Successful integration unlocks US$80 billion in bill pay total addressable market (TAM), expanding Xero's reach well beyond the US$15 billion accounting software market where Intuit's QuickBooks commands 70%-plus share. EBITDA margins have compressed from 31.7% to 8.5% as integration costs flow through, with stock-based compensation inflating from 6% to 13% of revenue post-acquisition. EBIT will remain negative through our forecast horizon to FY34 under IFRS treatment. The margin trough is by design rather than distress: free cash flow generation remained at NZ$534 million (25.4% margin) in FY25, converting 80% of EBITDA despite NZ$51 million in transaction costs.
The UK MTD catalyst provides a visible near-term growth driver independent of Melio. The April 2026 compliance deadline forces 4.5 million sole traders to adopt certified cloud software, and Xero launched its Simple product in November 2024, eighteen months ahead of the deadline, targeting 150,000 to 200,000 conversions worth NZ$250 to 350 million in incremental revenue by FY28-29. Xero holds 17% UK market share in a duopoly with Sage (40 to 45%), and Sage's desktop transition delays (60% cloud penetration versus Xero's 100%) provide a competitive window. The risk is that Sage achieves cloud product certification and restores competitive parity before Xero can lock in the MTD cohort.
Management credibility scores 7.5/10 in our pipeline, reflecting CEO Sukhinder Singh Cassidy's two-year tenure and a mixed M&A track record: Planday underperformed at 8% ROIC versus a 15% target, and Xero Go was impaired for NZ$29 million. Melio integration success, measured by 15 to 20% cross-sell penetration of Xero's 400,000 US subscribers generating NZ$50 to 70 million in annualised revenue by FY27, is the single most important milestone in the company's near-term trajectory.
Technology One: Outstanding Business, Extreme Valuation Disconnect
Technology One dominates Australian government ERP (enterprise resource planning, the software that runs finance, HR, and operations for large organisations) with 35% local government market share, 1% annual customer churn, 115% net revenue retention (meaning existing customers spend 15% more each year), and 16 consecutive years of record results. The SaaS+ bundled implementation model, which packages deployment services into the subscription price rather than billing them separately, produced a Rule of 40 score of 59%, placing it in the top global quartile. The company achieved its A$500 million annual recurring revenue target 18 months early and has raised its ambition to A$1 billion-plus by FY30. ROIC sits at 35% against an 11.8% weighted average cost of capital (WACC, the minimum return a company should earn to satisfy its debt and equity investors), a 23 percentage point value creation spread. The balance sheet holds A$319.6 million in cash with zero debt, and management credibility is 9.0/10.
The difficulty is that our fair value of A$7.65 against a market price of A$34.34 implies a 78% gap, the widest in this group. Our probability-weighted DCF produces A$4.56, and our dynamic weighted fair value incorporating peer multiples at partial weight reaches A$7.65. TNE trades at approximately 137x forward earnings and approximately 22x EV/EBITDA. Our DCF-implied EV/EBITDA is approximately 4.5x versus a SaaS sector median of 16.5x. The market is pricing perpetual high growth, but our model projects revenue growth decelerating from 18% today to approximately 3% by FY34, with ROIC declining from 35% to 25% as capital intensity rises and the consulting segment winds down from 14% to approximately 2% of revenue.
The competitive moat scores 6.8/10 with an estimated 5 to 7 year duration, which is below the peer average of 7.4/10. Switching costs (scored 9/10) are the strongest advantage: mission-critical ERP systems with A$500,000-plus implementation investments and 38 years of accumulated regulatory IP create genuine lock-in. But the SaaS+ model's first-mover advantage faces an 18 to 24 month competitive response window before major players like SAP, Oracle, and Workday can replicate bundled implementation approaches. The UK expansion is validating international scalability, with 49% ARR growth reaching A$51.8 million, though profit compressed to A$1.5 million from A$2.9 million in the prior year, revealing the capital intensity of geographic diversification.
The margin trajectory is the constraint the current price ignores. EBITDA margins sit at approximately 44%, which represents the historical peak. Our model projects compression to approximately 30% in FY26 as SaaS+ transition costs and UK investment absorb current profitability, recovering toward a 35% terminal range. Consulting segment margins have already compressed from 17% to 12.7%, approaching the 10% threshold below which the bundled pricing economics face structural questions. At A$34.34, an investor is paying 62x forward EPS for a business whose earnings growth rate will drop to low single digits within five years under our base case. The business is outstanding; the mathematics of the return from this price are not.
Pro Medicus: The Clearest Moat at the Most Extreme Price
Pro Medicus builds Visage 7, a cloud-native medical imaging platform that hospitals use to view, store, and manage patient scans such as X-rays, MRIs, and CT images. The company earns transaction-based fees each time a clinician accesses an image, a model generating 99.9% gross margins with near-zero variable costs. FY25 delivered 32% revenue growth to A$213 million with EBITDA margins expanding to 78%. Seven major hospital implementations are scheduled for H2 FY26, including the largest PACS (picture archiving and communication system) deployment in industry history at Trinity Health, which operates 93 hospitals across the United States. The A$1 billion contracted backlog provides three to five years of revenue visibility. Eleven of the top twenty US hospitals now use Visage 7. Business quality scores 8.4/10, management credibility 9.4/10, and return on invested capital exceeds 250%, the highest of any company we cover.
Our probability-weighted fair value is A$54.22. The current price of A$116.97 implies a 54% premium. The 90% confidence interval runs from A$40 to A$67. Our base case (70% probability) values PME at A$59, and our bear case (25% probability) at A$38. There is no bull scenario in our model that reaches the current market price. At A$116.97, the market is pricing sustained 30%-plus revenue growth at peak margins for over fifteen years with zero competitive response, applying a discount rate closer to 5 to 6%, which is a rate appropriate for infrastructure assets rather than a healthcare IT company.
The moat is genuine and widening. PME is the only true cloud-native imaging platform at scale. Its proprietary streaming architecture loads images in seconds versus minutes for legacy competitors, driving implementation times one-fifth of peers. Each Tier 1 hospital win strengthens reference-ability for the next. The 100% contract renewal rate across seven-year agreements creates a visible, compounding revenue base. The cardiology module is gaining traction, with management noting "material dividends" expected though specific contract wins have not been disclosed.
The two risks that the market is not pricing at A$117 are key-person concentration and Epic Systems entry. Founder Dr Sam Hupert has led PME for 40 years with no named successor, and the company's technology vision is closely associated with his leadership. Epic Systems controls 38% of US hospital electronic medical record (EMR) systems and could leverage that position to enter imaging through acquisition or product development. Our analysis assigns a 20% probability to Epic entry within three years, which would cap PME's addressable market share and compress pricing power, worth approximately A$21 per share of downside. Early warning signals include Epic M&A announcements or PME losing request-for-proposal competitions where Epic integration is cited as the deciding factor.
H1 FY26 revenue grew 28% to A$124.8 million, with EBITDA margins holding at 76%, down modestly from FY25's peak as implementation-driven hiring accelerated (employee costs up 44%). Free cash flow conversion remained at 90%. Full-year revenue is expected to reach A$275 to 290 million. The near-term catalysts include the Heidelberg University Hospital go-live in Europe (March 2026) and RSNA conference contract announcements (October 2026).
HUB24: Record Inflows at a Price That Requires a Bond-Like Discount Rate
HUB24 operates Australia's fastest-growing specialist investment platform, earning approximately 32 basis points (0.32%) on every dollar of client money advisers administer through its system. The more money on the platform, the more HUB24 earns. Platform FUA (funds under administration) reached A$127.9 billion at December 2025, up 29% year-on-year, with A$10.7 billion in net inflows representing a record half. Group EBITDA of A$104.9 million grew 35% on revenue of A$245.9 million, expanding the EBITDA margin from 39.8% to 42.7% in one half. Management has upgraded the FY27 FUA target to A$160 to 170 billion from A$148 to 162 billion, the second consecutive upgrade. The Class distribution subsidiary, with 6,600 accountant customers unavailable to competitor Netwealth, provides a structural channel advantage unique in the sector.
CEO Andrew Alcock holds approximately A$89 million in shares after a decade-plus tenure, and his management credibility score of 9.3/10 reflects consistent delivery: prior FUA targets have been exceeded both times they were set. The business scores 9.0/10 on our quality framework, the highest of any company in this group. The structural shift from institutional to specialist platforms has a decade of runway remaining: institutional platforms held approximately 87% of market share ten years ago and approximately 67% today. HUB24's adviser count of 5,277 grew 8% year-on-year, and revenue margin has held at 32 basis points across three consecutive reporting periods despite tiering and capping pressure that was expected to compress it further.
Our DCF fair value is A$42.23 using a WACC of 12%, which reflects HUB24's genuine risk profile: a platform business whose revenue is directly correlated with Australian equity markets, operating at the 93rd valuation percentile of the ASX. The 90% confidence interval runs from A$31.70 to A$52.80. Our base case (50% probability) values HUB at A$44.20, our bull case (20% probability) at A$52.30, our bear case (22% probability) at A$32.30, and our severe case (8% probability) at A$25.90. At A$97.50, the implied WACC is approximately 7.5%, which is the discount rate appropriate for a fixed income instrument, not an AUM-linked platform. The current market price sits 84% above the top of our 90% confidence range.
The operating leverage that makes the growth story compelling works in reverse during a drawdown. Each dollar of new FUA flows through a largely fixed cost base, producing operating leverage of 1.37x in the current year. If the ASX corrects 20%, FUA falls 10 to 12% almost immediately and revenue follows. At 38x forward EBITDA, a single quarter of slowing net inflows or a meaningful market correction could compress the multiple to its historical trough of 22 to 25x, representing a 30 to 40% drawdown from today's price without a single dollar of earnings being lost.
The myhub ecosystem, currently pre-revenue and entering pilot phase in 1HFY27, represents genuine option value on advice productivity monetisation. DBFO (Delivering Better Financial Outcomes) regulatory reforms are expanding the advice market. The trustee internalisation pending APRA approval adds a new recurring fee stream. None of these factors changes the discount rate problem at A$97.50.
Megaport: A Strong Network Business With an Unproven Acquisition
Megaport operates the world's largest software-defined network-as-a-service platform, connecting 8,500 enterprises across 1,034 data centres in 30 countries. Customers pay monthly to provision high-speed connections between cloud providers (AWS, Azure, Google Cloud) without touching physical hardware. The model produces 72% gross margins, net revenue retention of 111% (an all-time high, meaning existing customers increased their spending by 11% year-on-year), and customers who stay an average of 13 years. The structural multicloud tailwind has less than 5% total addressable market penetration, providing a long runway of organic growth.
H1 FY26 demonstrated that the organic network business is genuinely excellent. EBITDA of A$35.3 million at a 26.2% margin exceeded guidance of 21 to 24%. Americas ARR grew 24% in constant currency. Customer lifetime value rose 57% in constant currency terms. Revenue is forecast to grow 36% in FY26 and 29% in FY27, driven partly by the Latitude.sh acquisition.
At A$9.65 versus our fair value of A$7.05, the 27% gap is the second-narrowest in this group. Our fair value blends a probability-weighted DCF (61% weight, A$6.54) with trading multiples (39% weight, A$7.81). The bull case (10% probability) reaches A$9.87, and the bear case (25% probability) sits at A$4.85. We apply a 12.2% WACC reflecting acquisition uncertainty, versus the approximately 10.5% the market appears to imply.
The complication is the A$410 million Latitude.sh acquisition completed in December 2025, which added a GPU-as-a-service compute platform with five weeks of consolidated financial data, no disclosed margins, and A$345 million in goodwill. The stub period showed a small loss on A$5.8 million of compute revenue. We deduct the A$207 million Latitude.sh earnout liability as a debt-equivalent claim against equity, worth A$1.10 per share, while many market participants appear to exclude it. Management credibility scores 6.3/10, the lowest in this group, reflecting the A$410 million deployment on an acquisition where compute margins remain undisclosed.
The binary question is whether Latitude.sh hits its CY2026 revenue milestone of US$52 million. If it does and margins are disclosed as positive, the compute thesis gets its first concrete validation. If it misses, the A$345 million in goodwill becomes impairment risk. Meanwhile, the HQ cost line growing at 28% annually against 20.5% of revenue is the margin expansion bottleneck that management must address for FY28 and FY29 EBITDA targets to hold.
What Separates Earned from Hope
The pattern across these six companies reveals three variables that separate an earned premium from a hope premium.
The first is margin trajectory. PME's 76% EBITDA margins are real and have expanded for three consecutive years, supported by transaction-based pricing on a near-zero variable cost base. WTC's margins are temporarily compressed by the e2open integration but are guided to recover to 48% by FY29 with credible mechanisms: AI-driven headcount reduction, synergy run-rate achievement, and LGFF revenue ramp. TNE's 44% EBITDA margin sits at its historical peak, and our model projects compression toward 30% in FY26 and a 35% terminal as the consulting segment evaporates and SaaS+ transition costs flow through. HUB's 43% is still expanding, but it is directly linked to equity market levels that the ASX at its 93rd valuation percentile may not sustain. XRO's margin has deliberately collapsed from 32% to 8.5% as Melio integration absorbs profitability, with recovery to 12% by FY30 requiring the acquisition thesis to work. MP1's 26% margin exceeded guidance but faces dilution from compute economics that have not been disclosed. A premium is earned when margins are expanding on structural economics rather than cyclical tailwinds, peak conditions, or acquisition hope.
The second is capital efficiency. PME's 250% ROIC and TNE's 35% reflect genuinely capital-light models that generate outsized returns per dollar invested. But PME's ROIC is so high precisely because its invested capital base is minimal; what matters is whether absolute profit can grow fast enough to justify an A$12.2 billion market capitalisation. TNE's ROIC is projected to decline to 25% as platform investment rises, meaning the exceptional returns are partially historical. WTC's 22 to 24% ROIC is more representative of a scaled SaaS business carrying acquisition goodwill, and it is improving. HUB's 20% ROIC is solid but not exceptional for a platform business. XRO's 19% ROIC exceeds its 13.5% WACC, creating a 550 basis point value creation spread, but that spread is converging toward 150 basis points at terminal as competitive intensity rises. The highest ROIC does not always correlate with the best investment opportunity, because the market has already priced it.
The third is the discount rate debate. Every company in this group trades at an implied cost of capital below what our CAPM (capital asset pricing model) framework produces. WTC implies approximately 8 to 9% versus our 9.5%. TNE implies 5 to 6% versus our 11.8%. PME implies 5 to 6% versus our 10.9%. HUB implies 7.5% versus our 12%. XRO implies approximately 10% versus our 13.5%. MP1 implies approximately 10.5% versus our 12.2%. If risk-free rates normalise lower and equity risk premiums compress, these stocks deserve higher valuations. If the current rate environment persists, with the RBA at 3.85% and inflation at 3.8%, none of them offers adequate compensation for the capital at risk at these prices.
What Would Change Our View
More optimistic on WTC: EBITDA margin recovery to 45%-plus in the FY27 full-year result would confirm that the e2open integration and AI restructuring are delivering structural rather than guided benefits, worth approximately A$4 to 5 per share above our base case. Each 100 basis points of margin above our 45% FY27 assumption adds roughly A$0.80 per share. If e2open customer retention data, which has not been disclosed, shows churn below 5% in the first full year, the cascade risk that dominates our bear case diminishes substantially. Leverage declining below 2.5x by June 2026, ahead of the 3.0x target, would remove the refinancing overhang on the July 2027 Tranche A maturity.
More optimistic on XRO: Melio cross-sell penetration reaching 15 to 20% of Xero's 400,000 US subscribers (60,000 to 80,000 users) by September 2026 would validate the A$3.7 billion acquisition thesis and support the bull case of NZ$180.50 per share. UK MTD registrations accelerating above 500,000 per quarter would confirm that the TAM is materialising at the high end of the NZ$250 to 350 million revenue opportunity. ANZ churn stabilising at or below 0.81% monthly for two consecutive halves would reduce the probability weight on our churn normalisation scenario. Each of these milestones independently narrows the gap between our NZ$132.25 fair value and the current price; together, they would shift the probability weighting toward the bull case.
More optimistic on TNE: SaaS+ conversion rates progressing toward 70 to 75% from the current 45% baseline within two halves would confirm that bundled pricing economics work at scale without margin destruction, supporting A$0.85 per share of additional value. UK operations reaching breakeven to modest positive EBIT by FY27, ahead of our FY28 assumption, would validate international scalability. Consulting segment margins sustaining above 12% would address the structural question about whether the bundled model cannibalises the consulting revenue stream. None of these catalysts closes the 78% gap to the current price, but they would narrow the distance between our A$7.65 dynamic fair value and the A$4.56 probability-weighted DCF.
More optimistic on PME: Revenue acceleration above 30% in the FY26 full-year result driven by H2 go-lives (particularly Trinity Health's 93-hospital system) would confirm that the contracted backlog is converting faster than our model assumes. Cardiology module contract wins disclosed at scale would expand the addressable market within existing hospital relationships. Each major new Tier 1 hospital win narrows the Epic Systems entry probability, because hospital systems that have committed to Visage 7 are unlikely to switch back. A named successor to founder Dr Sam Hupert, even as a designated COO or CTO, would reduce the key-person risk discount embedded in our bear case. None of these developments justifies A$117, but a sustained conversion rate above our assumptions could push the base case toward A$65 to 70.
More optimistic on HUB: If HUB24 sustains above 18% net inflow rates beyond FY27 while holding revenue margin above 31 basis points, the FUA compounding rate produces earnings growth that can close the valuation gap over time without requiring a WACC compression argument. Each 100 basis points of reduction in the risk-free rate from the current 4.86% adds approximately 15% to our fair value estimate, so a sustained RBA easing cycle returning the 10-year bond toward 3.5% would add approximately A$11 per share to our A$42.23 base. The myhub ecosystem monetising at a meaningful SaaS price point by FY29, which is not in our base case, represents approximately A$5 to 7 per share of option value.
More optimistic on MP1: Latitude.sh hitting its CY2026 revenue milestone of US$52 million with disclosed positive margins would validate the compute thesis and support the bull case of A$9.87. Network EBITDA margins sustaining above 26% for two consecutive halves would confirm that organic operating leverage is structural rather than one-period outperformance. If the earnout liability can be restructured or paid from operating cash flow rather than equity dilution, the A$1.10 per share drag from our debt-equivalent treatment narrows.
Less optimistic on all six: A sustained ASX correction of 15 to 20% would simultaneously reduce HUB24's revenue base through FUA compression, weigh on WTC and XRO through currency and sentiment channels, compress PME's and TNE's growth multiples disproportionately given their extreme starting valuations, and test MP1's market implied discount rate assumptions. The February 2026 RBA rate increase to 3.85% and above-target inflation at 3.8% confirm that the environment supporting current equity valuations is not guaranteed to persist. At the 93rd valuation percentile, the asymmetry across the ASX is to the downside, and the companies in this group, trading 19 to 78% above our fair values, are disproportionately exposed to any repricing of the growth premium.
Bottom Line
The ASX technology sector contains some of the best businesses in the Australian market. Quality scores of 8 to 9, ROIC from 15% to 250%, recurring revenue models with sub-2% churn, and management teams with track records measured in decades. None of that is in question.
What our analysis finds is that the market has priced these qualities as though they eliminate risk entirely. WTC at a 19% premium is the closest to fair value and the most defensible hold for investors already positioned, with a genuine margin recovery catalyst in FY27 and a moat that regulation continues to widen. XRO at a 17% gap is a binary bet on Melio integration, with an outstanding core business that the market can currently access only by accepting the acquisition risk at a premium. TNE's 78% gap is the most extreme example of a high-quality business where the investment return mathematics do not work at the current price under any reasonable set of assumptions our model can generate. PME is the clearest example of a widening moat pushed past its limit: the quality justifies a premium, and at A$117 the premium has consumed all of the future returns the quality was supposed to generate. HUB24 is a structural winner in the wealth platform migration priced as though its equity-market-linked revenue deserves a bond-like discount rate. MP1 offers the most favourable risk-reward in the group on its organic network business, provided investors treat the compute acquisition as unproven optionality rather than embedded value.
The entry points that restore the risk-reward: WTC below A$35 brings the price inside our base case with LGFF and e2open optionality acquired at a discount. XRO below NZ$125 provides a genuine margin of safety on the core accounting platform with Melio optionality layered on top for free. TNE below A$8 aligns the price with our dynamic fair value, which already gives partial credit to peer multiples above our DCF output. PME below A$55 brings entry inside our probability-weighted fair value, where the contracted backlog and moat quality begin working for the investor rather than against them. HUB below A$45 provides margin of safety at our 12% WACC while preserving full exposure to the structural growth story. MP1 below A$7.00 values the network business alone, with compute optionality acquired for free.
Analysis generated by the Alpha Insights AI research pipeline. All fair values are point estimates subject to model uncertainty. This is not financial advice. Do your own research before making investment decisions.